Brain natriuretic peptide measurement

Doust JA, Pietrzak E, Dobson A, et al: How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005; 330(7492):625.

Kragelund C, Gronning B, Kober L, et al: N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352(7):666-675.

Doust JA, Glasziou PP, Pietrzak E, et al: A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004; 164:1978-1984.

Maisel A, Hollander JE, Guss D, et al: Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.. J Am Coll Cardiol 2004; 44(6):1328-1333.

Mueller C, Scholer A, Laule-Kilian K, et al: Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.. N Engl J Med 2004; 350:647-654.

Maisel AS, Krishnaswamy P, Nowak RM, et al: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347(3):161-167.

Rodeheffer RJ: Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004. J Am Coll Cardiol 2004; 44(4):740-749.

Yap LB, Mukerjee D, Timms PM, et al: Natriuretic peptides, respiratory disease, and the right heart. Chest 2004; 126(4):1330-1336.

Hunt SA, Baker DW, Chin MH, et al: ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001; 104(24):2996-3007.